Saulquin X, Ibisch C, Peyrat M A, Scotet E, Hourmant M, Vie H, Bonneville M, Houssaint E
INSERM U463, Institut de Biologie, Nantes, France.
Eur J Immunol. 2000 Sep;30(9):2531-9. doi: 10.1002/1521-4141(200009)30:9<2531::AID-IMMU2531>3.0.CO;2-O.
Knowledge of the immunodominant responses to Epstein-Barr Virus (EBV) and human cytomegalovirus (HCMV) should help to generate cytotoxic T cell lines to these herpesviruses. Here we report on the analysis of CD8 T cell responses to EBV and HCMV in the blood of kidney transplant recipients undergoing viral reactivation (n = 16) and in healthy virus carriers (n = 10). We used a transient COS transfection assay that permits semi-quantitative estimation of CD8+ T cell responses against a larger number of HLA/viral protein combinations within polyclonal T cell lines and thus allows a rapid identification of major epitopes. From the comparison of these responses to those that we previously described in the synovial fluid of patients suffering from various forms of chronic arthritis (n = 32), it appears that EBV-specific T cells are mainly directed against a restricted set of immunodominant epitopes, primarily generated during the early lytic cycle and that both IE1 and pp65 are targets of the anti-HCMV response. We suggest that this method could be generally applied to the rapid identification of immunodominant T cell epitopes in viral and tumor immunity, and could help selecting HLA-peptide complexes that could be used to detect and sort specific T cell populations.
了解针对爱泼斯坦-巴尔病毒(EBV)和人巨细胞病毒(HCMV)的免疫显性反应,应有助于生成针对这些疱疹病毒的细胞毒性T细胞系。在此,我们报告了对正在经历病毒再激活的肾移植受者(n = 16)和健康病毒携带者(n = 10)血液中CD8 T细胞对EBV和HCMV反应的分析。我们使用了一种瞬时COS转染检测方法,该方法允许对多克隆T细胞系中针对大量HLA/病毒蛋白组合的CD8 + T细胞反应进行半定量估计,从而能够快速鉴定主要表位。通过将这些反应与我们之前在患有各种形式慢性关节炎的患者(n = 32)滑液中描述的反应进行比较,似乎EBV特异性T细胞主要针对一组受限的免疫显性表位,这些表位主要在早期裂解周期产生,并且IE1和pp65都是抗HCMV反应的靶标。我们建议这种方法可普遍应用于快速鉴定病毒和肿瘤免疫中的免疫显性T细胞表位,并有助于选择可用于检测和分选特定T细胞群体的HLA-肽复合物。